Profile
Dr. Adam L. Tomasi is a President & Chief Operating Officer at Allakos, Inc. He is on the Board of Directors at Attune Pharmaceuticals, Inc. Dr. Tomasi was previously employed as a Chief Scientific Officer by ZS Pharma, Inc., a Principal by Alta Partners Management Corp., a Medicinal Chemist by Cytokinetics, Inc., and a Medicinal Chemist by Gilead Sciences, Inc. He received his undergraduate degree from the University of California, Berkeley, an MBA from MIT Sloan School of Management and a doctorate degree from the University of California, Irvine.
Adam Tomasi active positions
| Companies | Position | Start |
|---|---|---|
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Director/Board Member | - |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Director/Board Member | - |
Former positions of Adam Tomasi
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | Director of Finance/CFO | 18/04/2021 |
| ZS PHARMA INC | Chief Tech/Sci/R&D Officer | 28/02/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Private Equity Investor | - |
Training of Adam Tomasi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
ZS Pharma, Inc.
ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Adam Tomasi
















